Full Event Guide

Download the full agenda to explore:

• Safety, efficacy and scale-up of iPSC-derived constructs with Century Therapeutics, Exacis Biotherapeutics, Fate Therapeutics, Adaptimmune
• Novel allogeneic approaches as safe, efficacious and commercially viable treatment options with Kuur Therapeutics, Adicet Bio and Senti Biosciences
• Strategies to supercharge ‘thinking’ therapies against solid tumor indications with synthetic biology, multi-targeted and combination approaches with ArsenalBio, Allogene Therapeutics, CERo Therapeutics, Elpis Biopharma and Xyphos: An Astellas Company
• Technologies to integrate automation and streamlined manufacturing for consistency at scale and reduced cost of goods with Johnson & Johnson, Cellectis, Century Therapeutics and Legend Biotech
• Streamline regulatory strategy from Pre-IND to Post-BLA in a dedicated regulations bootcamp gathering thought leaders from BMS, Novartis, Kite, Celyad Oncology, GSK, and Peter Marks, FDA
• Insights into cell therapy industrialization, commercial readiness, and market access with the patient in mind, informed by global thought leaders from GSK, Kite, BMS, Novartis and many more